How automation simplifies patient collections

Collecting payments from patients has always been tough. Confusing bills, missed reminders and affordability concerns often lead to delays. Billing teams get bogged down in follow-up calls and paperwork, leaving little time for complex cases and a big question mark over whether they’re using their time efficiently. As patients shoulder a greater share of their…

Read More

Takeda R&D Exec Explains How $1.2B Deal Could Become One of the Biggest Bargains in Drug History

Bispecific antibodies are one of the hottest areas for drug research and dealmaking, and several of them were discussed this week during the annual J.P. Morgan Healthcare Conference in San Francisco. Takeda President, Research and Development, Andy Plump talked to MedCity News about what sets the Japanese pharma company’s newly licensed drug apart. The post…

Read More

Socktober 2025: Compass One Donates Over 300,000 Pairs of Socks Nationwide

Socktober Shatters Records Again!  “Socktober” continues to be a celebrated and engaging campaign for Compass One Healthcare associates across the country. This year, we’re proud to share that we not only met, but exceeded, our goals by collecting and donating more than 300,000 pairs of socks to charities nationwide.  Crothall teams played a major role in this year’s effort, with more…

Read More

How do drug prices change before loss of exclusivity?

Typically, cost effectiveness analyses assume a constant price between drug approvals and loss of exclusivity. It is not clear, however, to what extent that assumption is valid, particularly after taking into account drug price discounts and rebates. A paper by Lin et al. (2024) uses 2007-2023 data on drug prices from SSR Health to answer…

Read More